Skip to main content
Top
Published in: BMC Oral Health 1/2018

Open Access 01-12-2018 | Case report

Oral manifestation of Langerhans cell histiocytosis: a case report

Authors: Julia Luz, Daniel Zweifel, Martin Hüllner, Marco Bühler, Martin Rücker, Bernd Stadlinger

Published in: BMC Oral Health | Issue 1/2018

Login to get access

Abstract

Background

Bone necrosis of the jaw is a serious condition with a broad differential diagnosis of pathologies such as cutaneous histiocytosis, bone metastases or malignant tumours. In addition to the most common cause, medication related osteonecrosis of the jaw (MRONJ), one must consider a number of other causes, such as histiocytosis.
Langerhans cell histiocytosis (LCH) is a histiocytic disorder with a large spectrum of clinical manifestations and with possible involvement of a variety of organs. This case shows the importance of an early detection of this rare disease in order to prevent further spreading. Even if an initial diagnosis in the oral cavity is rare, dentists should be aware of this disease.

Case presentation

The presented case describes a patient who was referred for evaluation and treatment due to exposed bone and extensive osteolysis in the region of the upper and lower jaw. After biopsy and diagnosis of LCH, the patient was treated with systemic therapy, achieved remission and is disease free after a 2 year of follow up.

Conclusions

This case report illustrates that when dealing with unclear osteolytic changes of the jawbone, Langerhans cell histiocytosis must be taken into consideration in the differential diagnosis and biopsy must be performed in case of suspicion.
Literature
1.
go back to reference Allen CE, Li L, Peters TL, Leung HC, Yu A, Man TK, Gurusiddappa S, Phillips MT, Hicks MJ, Gaikwad A, et al. Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells. J Immunol. 2010;184(8):4557–67.CrossRefPubMedPubMedCentral Allen CE, Li L, Peters TL, Leung HC, Yu A, Man TK, Gurusiddappa S, Phillips MT, Hicks MJ, Gaikwad A, et al. Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells. J Immunol. 2010;184(8):4557–67.CrossRefPubMedPubMedCentral
2.
go back to reference Brown NA, Furtado LV, Betz BL, Kiel MJ, Weigelin HC, Lim MS, Elenitoba-Johnson KS. High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis. Blood. 2014;124(10):1655–8.CrossRefPubMed Brown NA, Furtado LV, Betz BL, Kiel MJ, Weigelin HC, Lim MS, Elenitoba-Johnson KS. High prevalence of somatic MAP2K1 mutations in BRAF V600E-negative Langerhans cell histiocytosis. Blood. 2014;124(10):1655–8.CrossRefPubMed
3.
go back to reference Badalian-Very G, Vergilio JA, Degar BA, MacConaill LE, Brandner B, Calicchio ML, Kuo FC, Ligon AH, Stevenson KE, Kehoe SM, et al. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood. 2010;116(11):1919–23.CrossRefPubMedPubMedCentral Badalian-Very G, Vergilio JA, Degar BA, MacConaill LE, Brandner B, Calicchio ML, Kuo FC, Ligon AH, Stevenson KE, Kehoe SM, et al. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood. 2010;116(11):1919–23.CrossRefPubMedPubMedCentral
4.
go back to reference Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, Requena-Caballero L, Jordan MB, Abdel-Wahab O, Allen CE, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016;127(22):2672–81.CrossRefPubMedPubMedCentral Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, Requena-Caballero L, Jordan MB, Abdel-Wahab O, Allen CE, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016;127(22):2672–81.CrossRefPubMedPubMedCentral
6.
go back to reference Marchand I, Barkaoui MA, Garel C, Polak M, Donadieu J, Writing C. Central diabetes insipidus as the inaugural manifestation of Langerhans cell histiocytosis: natural history and medical evaluation of 26 children and adolescents. J Clin Endocrinol Metab. 2011;96(9):E1352–60.CrossRefPubMed Marchand I, Barkaoui MA, Garel C, Polak M, Donadieu J, Writing C. Central diabetes insipidus as the inaugural manifestation of Langerhans cell histiocytosis: natural history and medical evaluation of 26 children and adolescents. J Clin Endocrinol Metab. 2011;96(9):E1352–60.CrossRefPubMed
7.
go back to reference Kilpatrick SE, Wenger DE, Gilchrist GS, Shives TC, Wollan PC, Unni KK. Langerhans' cell histiocytosis (histiocytosis X) of bone. A clinicopathologic analysis of 263 pediatric and adult cases. Cancer. 1995;76(12):2471–84.CrossRefPubMed Kilpatrick SE, Wenger DE, Gilchrist GS, Shives TC, Wollan PC, Unni KK. Langerhans' cell histiocytosis (histiocytosis X) of bone. A clinicopathologic analysis of 263 pediatric and adult cases. Cancer. 1995;76(12):2471–84.CrossRefPubMed
8.
9.
go back to reference Schultze A, Eckardt A, Kuske M. Langerhans-Zell-Histiozytose mit oraler manifestation. Mund-, Kiefer-und Gesichtschirurgie. 1999;3(3):158–64.CrossRefPubMed Schultze A, Eckardt A, Kuske M. Langerhans-Zell-Histiozytose mit oraler manifestation. Mund-, Kiefer-und Gesichtschirurgie. 1999;3(3):158–64.CrossRefPubMed
10.
go back to reference Facciolo M-T, Riva F, Gallenzi P, Patini R, Gaglioti D. A rare case of oral multisystem Langerhans cell histiocytosis. J Clin Exp Dent. 2017;9(6):e820.PubMedPubMedCentral Facciolo M-T, Riva F, Gallenzi P, Patini R, Gaglioti D. A rare case of oral multisystem Langerhans cell histiocytosis. J Clin Exp Dent. 2017;9(6):e820.PubMedPubMedCentral
12.
go back to reference Phillips M, Allen C, Gerson P, McClain K. Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis. Pediatr Blood Cancer. 2009;52(1):97–101.CrossRefPubMed Phillips M, Allen C, Gerson P, McClain K. Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis. Pediatr Blood Cancer. 2009;52(1):97–101.CrossRefPubMed
13.
go back to reference Obert J, Vercellino L, Van Der Gucht A, de Margerie-Mellon C, Bugnet E, Chevret S, Lorillon G, Tazi A. (18)F-fluorodeoxyglucose positron emission tomography-computed tomography in the management of adult multisystem Langerhans cell histiocytosis. Eur J Nucl Med Mol Imaging. 2017;44(4):598–610.CrossRefPubMed Obert J, Vercellino L, Van Der Gucht A, de Margerie-Mellon C, Bugnet E, Chevret S, Lorillon G, Tazi A. (18)F-fluorodeoxyglucose positron emission tomography-computed tomography in the management of adult multisystem Langerhans cell histiocytosis. Eur J Nucl Med Mol Imaging. 2017;44(4):598–610.CrossRefPubMed
14.
go back to reference Panis V, Nikitakis N, Daskalopoulos A, Maragkou T, Tsiklakis K, Sklavounou A. Langerhans cell histiocytosis mimicking aggressive periodontitis: challenges in diagnosis and management. Quintessence Int. 2016;47(9):731–8.PubMed Panis V, Nikitakis N, Daskalopoulos A, Maragkou T, Tsiklakis K, Sklavounou A. Langerhans cell histiocytosis mimicking aggressive periodontitis: challenges in diagnosis and management. Quintessence Int. 2016;47(9):731–8.PubMed
15.
go back to reference Eckardt A, Schultze A. Maxillofacial manifestations of Langerhans cell histiocytosis: a clinical and therapeutic analysis of 10 patients. Oral Oncol. 2003;39(7):687–94.CrossRefPubMed Eckardt A, Schultze A. Maxillofacial manifestations of Langerhans cell histiocytosis: a clinical and therapeutic analysis of 10 patients. Oral Oncol. 2003;39(7):687–94.CrossRefPubMed
16.
go back to reference Bartnick A, Friedrich RE, Roeser K, Schmelzle R. Oral Langerhans cell histiocytosis. J Craniomaxillofac Surg. 2002;30(2):91–6.CrossRefPubMed Bartnick A, Friedrich RE, Roeser K, Schmelzle R. Oral Langerhans cell histiocytosis. J Craniomaxillofac Surg. 2002;30(2):91–6.CrossRefPubMed
17.
go back to reference Putters TF, de Visscher JG, van Veen A, Spijkervet FK. Intralesional infiltration of corticosteroids in the treatment of localised langerhans' cell histiocytosis of the mandible report of known cases and three new cases. Int J Oral Maxillofac Surg. 2005;34(5):571–5.CrossRefPubMed Putters TF, de Visscher JG, van Veen A, Spijkervet FK. Intralesional infiltration of corticosteroids in the treatment of localised langerhans' cell histiocytosis of the mandible report of known cases and three new cases. Int J Oral Maxillofac Surg. 2005;34(5):571–5.CrossRefPubMed
18.
go back to reference Kriz J, Eich HT, Bruns F, Heyd R, Schafer U, Haverkamp U, Buntzel J, Seegenschmiedt H, Micke O. Radiotherapy in langerhans cell histiocytosis - a rare indication in a rare disease. Radiat Oncol. 2013;8:233.CrossRefPubMedPubMedCentral Kriz J, Eich HT, Bruns F, Heyd R, Schafer U, Haverkamp U, Buntzel J, Seegenschmiedt H, Micke O. Radiotherapy in langerhans cell histiocytosis - a rare indication in a rare disease. Radiat Oncol. 2013;8:233.CrossRefPubMedPubMedCentral
19.
go back to reference Arico M. Langerhans cell histiocytosis in children: from the bench to bedside for an updated therapy. Br J Haematol. 2016;173(5):663–70.CrossRefPubMed Arico M. Langerhans cell histiocytosis in children: from the bench to bedside for an updated therapy. Br J Haematol. 2016;173(5):663–70.CrossRefPubMed
20.
go back to reference Gadner H, Minkov M, Grois N, Potschger U, Thiem E, Arico M, Astigarraga I, Braier J, Donadieu J, Henter JI, et al. Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis. Blood. 2013;121(25):5006–14.CrossRefPubMed Gadner H, Minkov M, Grois N, Potschger U, Thiem E, Arico M, Astigarraga I, Braier J, Donadieu J, Henter JI, et al. Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis. Blood. 2013;121(25):5006–14.CrossRefPubMed
Metadata
Title
Oral manifestation of Langerhans cell histiocytosis: a case report
Authors
Julia Luz
Daniel Zweifel
Martin Hüllner
Marco Bühler
Martin Rücker
Bernd Stadlinger
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Oral Health / Issue 1/2018
Electronic ISSN: 1472-6831
DOI
https://doi.org/10.1186/s12903-018-0568-5

Other articles of this Issue 1/2018

BMC Oral Health 1/2018 Go to the issue